Tristel focuses on infection control products for acute NHS and private sector hospitals, as well as primary care trusts, community hospitals and private practices. Tristel also provides products for legionella control in water systems and contamination control in the food growing, food processing and pharmaceutical industries. Tristel is an aldehyde-free sterilant that can meet all the chemical decontamination needs of a hospital, safely and economically. As a result, Tristel has now become the most widely-used sterilant in UK hospitals. A patented chlorine dioxide chemistry used to sterilise medical, dental and veterinary instruments is the cornerstone of Tristel Solutions which was formed in Cambridgeshire, England in 1998. Tristel products are emerging as the leading replacements for aldehyde-based disinfectants, which have been the universal choice of disinfectant in all countries worldwide for the past two decades. However, because of health and environmental concerns, aldehyde-based disinfectants are being withdrawn in many countries. In England, Scotland and Wales, Tristel Solutions markets its products directly to National Health Service and private sector hospitals, GP practices, dental and veterinary establishments. The Tristel sterilants are manufactured in an ISO 9001:2000 accredited plant in Snailwell, England.
Company Growth (employees)
Type
Public
HQ
Snailwell, GB
Founded
1998
Size (employees)
111 (est)+13%
Tristel was founded in 1998 and is headquartered in Snailwell, GB

Tristel Office Locations

Tristel has an office in Snailwell
Snailwell, GB (HQ)
Fordham Rd
Show all (1)

Tristel Financials and Metrics

Tristel Financials

Tristel's revenue was reported to be £14.9 m in FY, 2016 which is a 2% increase from the previous period.
GBP

Revenue (FY, 2016)

14.9 m

Revenue growth (FY, 2015 - FY, 2016), %

12%

Gross profit (FY, 2016)

10.6 m

Gross profit margin (FY, 2016), %

71%

Net income (FY, 2016)

2.3 m

EBITDA (FY, 2016)

3 m

EBIT (FY, 2016)

2.6 m

Market capitalization (31-Oct-2017)

116.7 m

Closing share price (31-Oct-2017)

2.8

Cash (30-Jun-2016)

1.5 m
Tristel's current market capitalization is £116.7 m.
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4 m4.9 m5.9 m8 m9.3 m10.5 m10 m12.7 m14.7 m14.9 m

Revenue growth, %

28%14%12%

Cost of goods sold

1.5 m1.6 m2.1 m2.9 m3.5 m3.6 m3.7 m4.3 m4.8 m4.3 m

Gross profit

2.5 m3.4 m3.8 m5.1 m5.8 m6.8 m6.3 m8.4 m9.9 m10.6 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

49.6 k564.9 k210.2 k480.9 k98.8 k157.4 k(1.5 m)165.9 k1.3 m2.3 m

Cash From Operating Activities

338.9 k985.1 k715.5 k(223.2 k)3.4 m1.6 m377.8 k487.6 k2.8 m4.4 m

Dividends Paid

800 k2.8 m

Cash From Financing Activities

99.8 k1.3 k(47.2 k)(1.2 m)(1.2 m)(91.2 k)(60.2 k)(65.4 k)(860 k)(2.8 m)
    GBPY, 2016

    Revenue/Employee

    147.7 k

    Financial Leverage

    5.5 x
    Show all financial metrics

    Tristel Market Value History

    Tristel's Web-traffic and Trends

    Tristel Online and Social Media Presence

    Tristel Company Life and Culture

    You may also be interested in